Drug Discovery and Toxicity Screening

Discovering a new drug is difficult, tedious and expensive process, it can take up-to years and number of failures to develop a new successful drug.  In spite of this, many drugs fail later in the screening processes due to unseen toxic effects and side effects. Hence selection of appropriate models and assays to check on target is necessary to predict the toxicity at early stages and designing new paths in developing new successful drug. Early toxicity screening may help in eliminating the drugs which are not eligible for drug development processes.


  • Preclinical Drug Development
  • Preclinical Safety Assessment
  • Toxocological Testing
  • Predictive Toxicology
  • Drug Safety Biomarkers

Related Conference of Drug Discovery and Toxicity Screening

May 28-28, 2022

6th Webinar on Pharmacology and Toxicology

London, UK
May 30-31, 2022

Conference on Toxicology and Risk Assessment

Amsterdam, Netherlands
September 05-06, 2022

World Congress on Toxicology and Applied Pharmacology

Paris, France

Drug Discovery and Toxicity Screening Conference Speakers

Recommended Sessions

Related Journals

Are you interested in